Lobectomy/segmental resection
Conditions
Sponsors
Harbin Medical University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) 18 years old = age =75 years old, gender is not limited; (2) Non-small cell lung cancer clinically diagnosed as benign lesion or =?A stage: (3) thoracoscopic segmental/lobectomy was determined by the investigator; (4) Be able to cooperate with and complete follow-up and related examinations; (5) Voluntarily participate in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women; (2) severe coagulation dysfunction, obvious bleeding tendency; (3) Preoperative pulmonary insufficiency; (4) severe comorbidities that cannot tolerate surgery or anesthesia; (5) Combined with surgical site or systemic infection, severe inflammatory reaction; (6) Emergency surgery; (7) Complicated with severe pleural adhesion and massive pleural effusion; (8) Multiple organ resection (additional surgical removal of surrounding tissues and organs); (9) Participants in other investigational drug or device clinical trials have not been completed; (10) Patients considered unsuitable for participation in this project by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No conversion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of lymph node dissection; | — |
Countries
China
Contacts
Public ContactXu Shidong
Harbin Medical University Cancer Hospital
Outcome results
None listed